Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.

We describe a kindred with slowly progressive gastrointestinal symptoms and autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. The amyloid consists of Asp76Asn variant β(2)-microglobulin. Unlike patients with dialysis-related amyloidosis caused by sustained high plasma concentrations of wild-type β(2)-microglobulin, the affected members of this kindred had normal renal function and normal circulating β(2)-microglobulin values. The Asp76Asn β(2)-microglobulin variant was thermodynamically unstable and remarkably fibrillogenic in vitro under physiological conditions. Previous studies of β(2)-microglobulin aggregation have not shown such amyloidogenicity for single-residue substitutions. Comprehensive biophysical characterization of the β(2)-microglobulin variant, including its 1.40-Å, three-dimensional structure, should allow further elucidation of fibrillogenesis and protein misfolding.

[1]  G. Brezesinski,et al.  Triggers for β-sheet formation at the hydrophobic-hydrophilic interface: high concentration, in-plane orientational order, and metal ion complexation. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[2]  S. Radford,et al.  Understanding the complex mechanisms of β2-microglobulin amyloid assembly , 2011, The FEBS journal.

[3]  L. Wyns,et al.  Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic β2-microglobulin variant , 2011, Proceedings of the National Academy of Sciences.

[4]  A. Gliozzi,et al.  Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid Fibrils*♦ , 2010, The Journal of Biological Chemistry.

[5]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[6]  M. Pepys A molecular correlate of clinicopathology in transthyretin amyloidosis , 2009, The Journal of pathology.

[7]  M. Bolognesi,et al.  The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. , 2008, Journal of molecular biology.

[8]  G. Esposito,et al.  Lysine 58‐cleaved β2‐microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis‐related amyloidosis , 2006, Protein science : a publication of the Protein Society.

[9]  M. J. Parker,et al.  Amyloid formation under physiological conditions proceeds via a native-like folding intermediate , 2006, Nature Structural &Molecular Biology.

[10]  M. Cogné,et al.  Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Alessandra Corazza,et al.  β2‐Microglobulin isoforms display an heterogeneous affinity for type I collagen , 2005, Protein science : a publication of the Protein Society.

[12]  M. Sunde,et al.  Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure , 2001, Protein science : a publication of the Protein Society.

[13]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[14]  J. Hamilton,et al.  The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30→Met variant to 1.7-Å resolution , 1993 .

[15]  J. Floege,et al.  Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. , 1991, The Journal of laboratory and clinical medicine.

[16]  M. Pepys,et al.  Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. , 1990, The New England journal of medicine.

[17]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[18]  I. Ginjaar,et al.  The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. , 1987, Journal of immunology.

[19]  J. Rotés-Querol,et al.  Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication. , 1985, Annals of the rheumatic diseases.

[20]  M Arakawa,et al.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.

[21]  Fabrizio Chiti,et al.  Amyloid formation by globular proteins under native conditions. , 2009, Nature chemical biology.

[22]  F. Gejyo,et al.  Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  M. Pepys,et al.  Congo red overlay immunohistochemistry aids classification of amyloid deposits , 1999 .

[24]  G. Tennent,et al.  Isolation and characterization of amyloid fibrils from tissue. , 1999, Methods in enzymology.

[25]  M. Nybo,et al.  Amyloid and Amyloidosis 1998 , 1999 .

[26]  Satoru Suzuki,et al.  Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .